Nucleoside Analog Antiviral [EPC]

Nucleoside Analog Antiviral [EPC] was reported 85500 times

Drugs of the Nucleoside Analog Antiviral [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANAL PRURITUS 819 0.3943
1 ENCEPHALITIS CYTOMEGALOVIRUS 171 0.3904
2 VOGT-KOYANAGI-HARADA SYNDROME 38 0.3393
3 HEPATITIS C RNA POSITIVE 58 0.3392
4 ANORECTAL DISCOMFORT 1660 0.3120
5 HEPATITIS C RNA INCREASED 103 0.3012
6 CYTOMEGALOVIRUS SYNDROME 45 0.2727
7 SMOOTH MUSCLE CELL NEOPLASM 108 0.2584
8 AMAUROSIS FUGAX 232 0.2154
9 HEPATITIS C 2251 0.1863
10 GENOTYPE DRUG RESISTANCE TEST POSITIVE 183 0.1780
11 PORPHYRIA NON-ACUTE 69 0.1586
12 HEPATIC CANCER RECURRENT 44 0.1549
13 REMISSION NOT ACHIEVED 96 0.1543
14 CYTOMEGALOVIRUS GASTRITIS 39 0.1542
15 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 44 0.1477
16 CHRONIC HEPATITIS C 56 0.1418
17 HEPATOCELLULAR CARCINOMA 976 0.1282
18 HEPATITIS E 193 0.1222
19 PAINFUL DEFAECATION 81 0.1164
20 CYTOMEGALOVIRUS OESOPHAGITIS 41 0.1114
21 VIRAL LOAD INCREASED 431 0.1109
22 CYTOMEGALOVIRUS CHORIORETINITIS 209 0.1071
23 CRYOGLOBULINAEMIA 76 0.1063
24 RETINAL EXUDATES 98 0.1047
25 PNEUMONIA CYTOMEGALOVIRAL 192 0.0988
26 CYTOMEGALOVIRUS VIRAEMIA 439 0.0986
27 EPSTEIN-BARR VIRAEMIA 106 0.0956
28 CYTOMEGALOVIRUS INFECTION REACTIVATION 408 0.0923
29 CYTOMEGALOVIRUS COLITIS 201 0.0873
30 BLEEDING VARICOSE VEIN 45 0.0832
31 PROCTALGIA 527 0.0819
32 HEPATITIS C VIRUS TEST POSITIVE 48 0.0816
33 VIRAL HAEMORRHAGIC CYSTITIS 58 0.0815
34 OESOPHAGEAL VARICES HAEMORRHAGE 167 0.0769
35 CYTOMEGALOVIRUS INFECTION 1256 0.0755
36 CYTOMEGALOVIRUS ENTEROCOLITIS 53 0.0688
37 HUMAN HERPESVIRUS 8 INFECTION 41 0.0673
38 LIVER TRANSPLANT REJECTION 118 0.0656
39 NECROTISING RETINITIS 42 0.0656
40 ANORECTAL DISORDER 126 0.0631
41 RETINOPATHY 226 0.0605
42 CYTOMEGALOVIRUS TEST POSITIVE 105 0.0589
43 BK VIRUS INFECTION 196 0.0581
44 PARVOVIRUS B19 INFECTION 51 0.0570
45 GLOMERULOSCLEROSIS 36 0.0570
46 HEPATIC ENCEPHALOPATHY 531 0.0568
47 VARICES OESOPHAGEAL 168 0.0555
48 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 78 0.0552
49 HYPERBILIRUBINAEMIA 565 0.0545
50 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 273 0.0536
51 CYSTITIS HAEMORRHAGIC 213 0.0528
52 HYPERURICAEMIA 214 0.0520
53 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 68 0.0516
54 HEPATORENAL SYNDROME 87 0.0515
55 HAEMORRHOIDS 999 0.0512
56 SCEDOSPORIUM INFECTION 36 0.0510
57 LIVER TRANSPLANT 185 0.0508
58 BILIRUBIN CONJUGATED INCREASED 116 0.0496
59 EXPOSURE VIA DIRECT CONTACT 46 0.0484
60 URINARY TRACT DISORDER 214 0.0475
61 ANAEMIA 9059 0.0474
62 ASCITES 1396 0.0474
63 COLORECTAL CANCER METASTATIC 110 0.0464
64 HEPATIC CIRRHOSIS 853 0.0454
65 VIROLOGIC FAILURE 242 0.0450
66 HEPATITIS B REACTIVATION 137 0.0431
67 RED BLOOD CELL COUNT DECREASED 1219 0.0426
68 FUNGAL SEPSIS 35 0.0421
69 EPSTEIN-BARR VIRUS INFECTION 263 0.0421
70 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 65 0.0405
71 TRANSPLANT REJECTION 320 0.0399
72 VIRAL MUTATION IDENTIFIED 147 0.0399
73 HAEMOLYTIC ANAEMIA 357 0.0398
74 HEPATIC NEOPLASM MALIGNANT 84 0.0396
75 PATHOGEN RESISTANCE 360 0.0395
76 VIRAEMIA 54 0.0390
77 GRAFT VERSUS HOST DISEASE IN SKIN 83 0.0376
78 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 80 0.0376
79 WHITE BLOOD CELL COUNT DECREASED 4067 0.0375
80 HEPATIC FAILURE 1129 0.0374
81 ADENOVIRUS INFECTION 108 0.0372
82 PNEUMOCYSTIS JIROVECII INFECTION 44 0.0368
83 BLOOD BILIRUBIN INCREASED 994 0.0368
84 INCISION SITE PAIN 42 0.0357
85 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 63 0.0356
86 INFECTION REACTIVATION 40 0.0349
87 HEPATIC PAIN 149 0.0349
88 APLASIA PURE RED CELL 120 0.0348
89 HAEMORRHAGIC STROKE 272 0.0348
90 ANAL HAEMORRHAGE 96 0.0342
91 RASH GENERALISED 862 0.0333
92 GRAFT VERSUS HOST DISEASE 232 0.0322
93 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 89 0.0322
94 ACINETOBACTER INFECTION 35 0.0320
95 HAEMORRHOIDAL HAEMORRHAGE 156 0.0319
96 ACUTE GRAFT VERSUS HOST DISEASE 146 0.0319
97 PORTAL VEIN THROMBOSIS 102 0.0315
98 TRANSPLANT FAILURE 76 0.0310
99 DRUG RESISTANCE 793 0.0308
100 PORTAL HYPERTENSION 95 0.0308
101 BONE MARROW TOXICITY 36 0.0304
102 GENERALISED OEDEMA 370 0.0299
103 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 95 0.0292
104 HAEMOGLOBIN DECREASED 2938 0.0286
105 CARCINOEMBRYONIC ANTIGEN INCREASED 55 0.0284
106 ASPERGILLOSIS 37 0.0283
107 INFLUENZA LIKE ILLNESS 2331 0.0283
108 HEPATIC FIBROSIS 97 0.0282
109 APLASTIC ANAEMIA 147 0.0281
110 TRANSPLANT DYSFUNCTION 50 0.0280
111 AMMONIA INCREASED 142 0.0278
112 PLATELET COUNT DECREASED 2957 0.0277
113 NEUTROPHIL COUNT DECREASED 1101 0.0270
114 JAUNDICE 698 0.0259
115 LEUKOPENIA 1296 0.0259
116 TRANSFUSION 268 0.0256
117 PRURITUS GENERALISED 552 0.0255
118 NO THERAPEUTIC RESPONSE 310 0.0254
119 CYTOPENIA 311 0.0254
120 PANCYTOPENIA 1417 0.0253
121 NEPHROPATHY TOXIC 282 0.0251
122 BLOOD URIC ACID INCREASED 145 0.0251
123 STENOTROPHOMONAS INFECTION 34 0.0251
124 ENTEROCOCCAL INFECTION 121 0.0250
125 MUCORMYCOSIS 65 0.0250
126 BLOOD COUNT ABNORMAL 379 0.0250
127 STOMA SITE HAEMORRHAGE 37 0.0240
128 OCULAR DISCOMFORT 269 0.0239
129 KLEBSIELLA INFECTION 120 0.0237
130 RASH PRURITIC 1278 0.0236
131 HUMAN HERPESVIRUS 6 INFECTION 43 0.0227
132 ASPERGILLUS INFECTION 149 0.0227
133 FACIAL PALSY 49 0.0227
134 THROMBOTIC MICROANGIOPATHY 220 0.0226
135 CHRONIC GRAFT VERSUS HOST DISEASE 79 0.0219
136 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 72 0.0218
137 RETINAL HAEMORRHAGE 152 0.0213
138 HAEMOLYSIS 163 0.0211
139 HEPATIC NEOPLASM 68 0.0208
140 COMPLICATIONS OF TRANSPLANTED KIDNEY 47 0.0207
141 FAECES PALE 46 0.0207
142 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 154 0.0205
143 COLON CANCER METASTATIC 33 0.0205
144 ORAL INTAKE REDUCED 49 0.0202
145 RETINITIS 35 0.0202
146 HEPATITIS CHOLESTATIC 122 0.0202
147 HAEMATEMESIS 511 0.0201
148 OCULAR ICTERUS 87 0.0201
149 LUNG ABSCESS 42 0.0200
150 DYSGEUSIA 1485 0.0200
151 APHTHOUS STOMATITIS 46 0.0199
152 PHOTOPHOBIA 367 0.0195
153 BRONCHOPULMONARY ASPERGILLOSIS 151 0.0195
154 STAPHYLOCOCCAL SEPSIS 96 0.0194
155 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 48 0.0194
156 VARICELLA ZOSTER VIRUS INFECTION 40 0.0193
157 KIDNEY TRANSPLANT REJECTION 92 0.0192
158 ESCHERICHIA SEPSIS 55 0.0190
159 IRRITABILITY 1141 0.0190
160 BACTERIAL SEPSIS 61 0.0187
161 FIBROSIS 57 0.0185
162 VIITH NERVE PARALYSIS 63 0.0182
163 BLOOD IRON INCREASED 34 0.0181
164 MULTIPLE ORGAN DYSFUNCTION SYNDROME 512 0.0181
165 HOMICIDAL IDEATION 73 0.0180
166 CHILLS 2107 0.0180
167 BILE DUCT OBSTRUCTION 34 0.0179
168 ADENOCARCINOMA OF COLON 33 0.0176
169 DECREASED APPETITE 4071 0.0175
170 DISEASE PROGRESSION 2066 0.0174
171 PERITONITIS BACTERIAL 175 0.0173
172 CD4 LYMPHOCYTES DECREASED 37 0.0173
173 RASH PAPULAR 387 0.0172
174 PNEUMOCYSTIS JIROVECII PNEUMONIA 173 0.0172
175 ESCHERICHIA BACTERAEMIA 40 0.0170
176 THROMBOCYTOPENIA 1845 0.0165
177 AUTOIMMUNE HEPATITIS 114 0.0164
178 NEUTROPENIA 2211 0.0162
179 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 38 0.0162
180 SARCOIDOSIS 77 0.0162
181 ACUTE PSYCHOSIS 40 0.0162
182 BRAIN HERNIATION 48 0.0161
183 RENAL TUBULAR DISORDER 45 0.0160
184 STAPHYLOCOCCAL BACTERAEMIA 69 0.0159
185 AUTOIMMUNE THYROIDITIS 60 0.0159
186 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 79 0.0158
187 HISTIOCYTOSIS HAEMATOPHAGIC 46 0.0155
188 MULTI-ORGAN FAILURE 267 0.0154
189 APHAGIA 74 0.0154
190 YELLOW SKIN 72 0.0154
191 NEUROLOGICAL DECOMPENSATION 35 0.0151
192 BLOOD DISORDER 121 0.0151
193 TONGUE ULCERATION 51 0.0151
194 MOOD SWINGS 479 0.0150
195 PULMONARY TUBERCULOSIS 64 0.0150
196 LYMPHOPENIA 210 0.0148
197 ENCEPHALOPATHY 364 0.0148
198 HEAD DISCOMFORT 262 0.0148
199 HAEMATOCRIT DECREASED 293 0.0148
200 CHOLANGITIS 91 0.0147
201 HAEMATOTOXICITY 138 0.0145
202 CANCER PAIN 37 0.0145
203 BLOOD ALBUMIN DECREASED 114 0.0144
204 ALTERED STATE OF CONSCIOUSNESS 311 0.0143
205 SPLENOMEGALY 168 0.0143
206 ORAL CANDIDIASIS 188 0.0143
207 FATIGUE 11102 0.0142
208 RASH VESICULAR 68 0.0140
209 FEELING OF BODY TEMPERATURE CHANGE 82 0.0140
210 CANDIDIASIS 56 0.0139
211 GLOMERULONEPHRITIS 34 0.0139
212 HYPERLACTACIDAEMIA 37 0.0138
213 PSEUDOMONAS INFECTION 118 0.0137
214 HYPOGAMMAGLOBULINAEMIA 90 0.0137
215 PAROSMIA 103 0.0136
216 HEPATOSPLENOMEGALY 35 0.0136
217 BONE MARROW FAILURE 277 0.0136
218 CACHEXIA 70 0.0136
219 TREATMENT FAILURE 1125 0.0136
220 CHAPPED LIPS 58 0.0133
221 DEPRESSIVE SYMPTOM 47 0.0133
222 INSOMNIA 3549 0.0133
223 SERUM FERRITIN INCREASED 69 0.0131
224 CHROMATURIA 295 0.0131
225 BRAIN ABSCESS 33 0.0130
226 PYREXIA 4454 0.0129
227 PRESYNCOPE 312 0.0128
228 RASH 5587 0.0128
229 LYMPHOPROLIFERATIVE DISORDER 37 0.0126
230 CHEILITIS 68 0.0126
231 NEPHROTIC SYNDROME 85 0.0124
232 RECTAL HAEMORRHAGE 532 0.0124
233 VENOOCCLUSIVE LIVER DISEASE 61 0.0123
234 PRURITUS 4735 0.0123
235 RETINAL DETACHMENT 113 0.0123
236 RENAL IMPAIRMENT 1030 0.0122
237 SEPTIC SHOCK 532 0.0122
238 HYPOALBUMINAEMIA 95 0.0122
239 PROCTITIS 34 0.0121
240 ANGER 409 0.0121
241 ENCEPHALITIS 83 0.0120
242 MULTIPLE-DRUG RESISTANCE 37 0.0119
243 ERYTHEMA MULTIFORME 111 0.0119
244 DEAFNESS NEUROSENSORY 39 0.0118
245 BACTERAEMIA 139 0.0117
246 TONGUE DISCOLOURATION 51 0.0117
247 THYROIDITIS 35 0.0116
248 DEPRESSION 2642 0.0116
249 HEPATIC LESION 50 0.0116
250 BLOOD POTASSIUM DECREASED 345 0.0115
251 SEPSIS 1275 0.0114
252 LIVER ABSCESS 37 0.0114
253 DEHYDRATION 1519 0.0114
254 PHOTOSENSITIVITY REACTION 188 0.0114
255 HERPES VIRUS INFECTION 65 0.0113
256 ASTHENIA 4239 0.0113
257 ANOREXIA 145 0.0112
258 NAUSEA 8861 0.0112
259 PNEUMONIA BACTERIAL 101 0.0110
260 PNEUMONIA VIRAL 35 0.0110
261 WEIGHT DECREASED 3053 0.0109
262 HAEMATURIA 374 0.0109
263 BRONCHOPNEUMONIA 37 0.0108
264 CHOLECYSTITIS ACUTE 61 0.0108
265 STOMATITIS 645 0.0106
266 ACUTE RESPIRATORY DISTRESS SYNDROME 188 0.0106
267 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 273 0.0106
268 CANDIDA INFECTION 179 0.0106
269 CLOSTRIDIUM DIFFICILE COLITIS 112 0.0106
270 OESOPHAGEAL CANDIDIASIS 42 0.0105
271 DISSEMINATED INTRAVASCULAR COAGULATION 148 0.0105
272 DIPLOPIA 272 0.0105
273 MALNUTRITION 117 0.0104
274 DIARRHOEA HAEMORRHAGIC 97 0.0104
275 ORAL PAIN 232 0.0104
276 ESCHERICHIA URINARY TRACT INFECTION 44 0.0103
277 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 39 0.0102
278 ENDOCARDITIS 52 0.0101
279 THIRST 181 0.0101
280 TOXIC SKIN ERUPTION 102 0.0101
281 THYROID FUNCTION TEST ABNORMAL 42 0.0101
282 EYE PAIN 570 0.0101
283 DRY MOUTH 814 0.0100
284 HYDRONEPHROSIS 75 0.0100
285 HERPES SIMPLEX 65 0.0100
286 DRUG ERUPTION 176 0.0099
287 THYROID DISORDER 153 0.0099
288 LOCAL SWELLING 173 0.0099
289 BLOOD UREA INCREASED 166 0.0099
290 VOMITING 4652 0.0099
291 THERAPEUTIC PRODUCT INEFFECTIVE 38 0.0098
292 IMMUNE THROMBOCYTOPENIA 45 0.0098
293 HYPERAMMONAEMIA 49 0.0098
294 ALANINE AMINOTRANSFERASE INCREASED 601 0.0098
295 ESCHERICHIA INFECTION 80 0.0097
296 B-CELL LYMPHOMA 33 0.0097
297 FAECES DISCOLOURED 210 0.0097
298 HEPATOMEGALY 95 0.0097
299 APPETITE DISORDER 64 0.0096
300 GINGIVAL BLEEDING 131 0.0096
301 MOUTH ULCERATION 201 0.0095
302 GUILLAIN-BARRE SYNDROME 46 0.0095
303 INJECTION SITE RASH 291 0.0095
304 HYPERTHYROIDISM 137 0.0095
305 PROTEIN URINE PRESENT 47 0.0094
306 LETHARGY 542 0.0094
307 RASH ERYTHEMATOUS 449 0.0094
308 SKIN DISORDER 307 0.0092
309 DYSPNOEA EXERTIONAL 346 0.0092
310 GINGIVAL PAIN 73 0.0092
311 EPISTAXIS 686 0.0092
312 HAEMORRHAGE INTRACRANIAL 136 0.0091
313 PLEURISY 54 0.0091
314 ORGANISING PNEUMONIA 45 0.0091
315 PULMONARY HAEMORRHAGE 71 0.0091
316 TEARFULNESS 39 0.0091
317 OPTIC ISCHAEMIC NEUROPATHY 35 0.0090
318 ENTEROCOLITIS 52 0.0090
319 TONGUE DISORDER 65 0.0090
320 FULL BLOOD COUNT DECREASED 181 0.0090
321 RENAL FAILURE ACUTE 381 0.0090
322 TYPE 1 DIABETES MELLITUS 54 0.0090
323 ALCOHOL USE 33 0.0089
324 GASTRIC ULCER 169 0.0089
325 LUNG INFECTION 138 0.0089
326 BLOOD CREATININE INCREASED 576 0.0088
327 GASTROINTESTINAL INFECTION 79 0.0088
328 HYPERAESTHESIA 72 0.0088
329 TINNITUS 402 0.0087
330 AFFECT LABILITY 84 0.0087
331 FEELING COLD 243 0.0087
332 HYPOVOLAEMIA 51 0.0087
333 HAEMOGLOBIN ABNORMAL 56 0.0087
334 DRY SKIN 1159 0.0087
335 ASPARTATE AMINOTRANSFERASE INCREASED 459 0.0086
336 TRANSAMINASES INCREASED 191 0.0086
337 MYALGIA 1457 0.0086
338 PYELONEPHRITIS 74 0.0085
339 OLIGURIA 53 0.0085
340 RESPIRATORY DISTRESS 235 0.0085
341 DISTURBANCE IN ATTENTION 459 0.0085
342 BLINDNESS 345 0.0085
343 NASAL DRYNESS 53 0.0084
344 ALCOHOLISM 36 0.0084
345 BODY TEMPERATURE INCREASED 171 0.0084
346 ALOPECIA 1637 0.0083
347 SYNCOPE 834 0.0083
348 HEPATIC FUNCTION ABNORMAL 311 0.0083
349 RESPIRATORY FAILURE 607 0.0083
350 BACTERIAL INFECTION 155 0.0083
351 ELECTROLYTE IMBALANCE 96 0.0083
352 GRANULOCYTOPENIA 47 0.0082
353 MENINGITIS 55 0.0082
354 SLUGGISHNESS 84 0.0082
355 RASH MACULO-PAPULAR 183 0.0082
356 HYPERSOMNIA 235 0.0082
357 FLUID INTAKE REDUCED 41 0.0082
358 DIARRHOEA 5282 0.0082
359 INCREASED UPPER AIRWAY SECRETION 42 0.0082
360 ORAL HERPES 159 0.0081
361 PROCEDURAL COMPLICATION 62 0.0081
362 GASTROENTERITIS 118 0.0081
363 FURUNCLE 64 0.0081
364 HEADACHE 5058 0.0081
365 MOUTH HAEMORRHAGE 59 0.0080
366 FORMICATION 56 0.0080
367 END STAGE RENAL DISEASE 146 0.0080
368 HEPATIC CANCER 192 0.0080
369 LIVER DISORDER 354 0.0080
370 DECREASED INTEREST 47 0.0080
371 DRY THROAT 81 0.0080
372 SQUAMOUS CELL CARCINOMA OF SKIN 48 0.0079
373 ACUTE HEPATIC FAILURE 108 0.0079
374 WHITE BLOOD CELL COUNT ABNORMAL 50 0.0078
375 SKIN ULCER 202 0.0078
376 DERMATITIS EXFOLIATIVE 39 0.0078
377 HYPOPHAGIA 199 0.0078
378 VASCULITIS 90 0.0077
379 SUBCUTANEOUS ABSCESS 37 0.0077
380 COMA 367 0.0077
381 MOOD ALTERED 209 0.0077
382 ENTERITIS 49 0.0076
383 PANCREATITIS ACUTE 172 0.0076
384 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 73 0.0076
385 DEPRESSED MOOD 404 0.0076
386 LUNG INFILTRATION 67 0.0076
387 SINUS HEADACHE 45 0.0076
388 CARDIO-RESPIRATORY ARREST 316 0.0075
389 ABDOMINAL PAIN 1745 0.0075
390 PARANOIA 129 0.0075
391 BLOOD TEST ABNORMAL 105 0.0075
392 FLANK PAIN 70 0.0075
393 STAPHYLOCOCCAL INFECTION 246 0.0075
394 ANAL FISSURE 40 0.0075
395 SKIN REACTION 105 0.0074
396 UPPER GASTROINTESTINAL HAEMORRHAGE 125 0.0074
397 HAEMATOCHEZIA 410 0.0074
398 BLOOD IRON DECREASED 88 0.0074
399 GLOSSODYNIA 166 0.0074
400 HYPOMAGNESAEMIA 103 0.0074
401 BLISTER 415 0.0074
402 RENAL FAILURE 981 0.0074
403 LYMPHADENOPATHY 261 0.0074
404 SHOCK HAEMORRHAGIC 60 0.0074
405 DIZZINESS POSTURAL 71 0.0073
406 MACULAR OEDEMA 41 0.0073
407 MYELOSUPPRESSION 263 0.0073
408 HEPATITIS B 44 0.0073
409 GASTROINTESTINAL TOXICITY 35 0.0073
410 AGRANULOCYTOSIS 135 0.0073
411 EMOTIONAL DISORDER 223 0.0072
412 MENTAL DISORDER 314 0.0072
413 CRYING 261 0.0072
414 PSYCHIATRIC SYMPTOM 53 0.0072
415 FACE OEDEMA 121 0.0072
416 ERYSIPELAS 36 0.0072
417 IRON DEFICIENCY ANAEMIA 66 0.0071
418 VISION BLURRED 978 0.0071
419 ACUTE RESPIRATORY FAILURE 136 0.0071
420 HYPOKALAEMIA 326 0.0071
421 ABDOMINAL TENDERNESS 35 0.0070
422 HAEMOPTYSIS 196 0.0070
423 PALLOR 189 0.0069
424 IMMUNOSUPPRESSION 61 0.0069
425 HYPERTRANSAMINASAEMIA 48 0.0069
426 RETCHING 147 0.0069
427 DYSURIA 253 0.0069
428 ODYNOPHAGIA 41 0.0069
429 APPENDICITIS 64 0.0068
430 NEUTROPHIL COUNT INCREASED 70 0.0068
431 RENAL TUBULAR NECROSIS 67 0.0068
432 ORAL DISORDER 50 0.0068
433 HYPOTHYROIDISM 217 0.0068
434 RASH MACULAR 237 0.0068
435 BLOOD SODIUM DECREASED 127 0.0067
436 CHOLECYSTITIS 80 0.0067
437 SKIN LESION 184 0.0067
438 PROTHROMBIN TIME PROLONGED 40 0.0067
439 IMMUNE SYSTEM DISORDER 88 0.0067
440 PSYCHOTIC DISORDER 197 0.0067
441 CHOLESTASIS 128 0.0067
442 SMALL INTESTINAL OBSTRUCTION 82 0.0067
443 MASS 93 0.0066
444 MUSCLE ATROPHY 84 0.0066
445 ATELECTASIS 64 0.0066
446 DIFFUSE LARGE B-CELL LYMPHOMA 51 0.0066
447 GASTRITIS 174 0.0066
448 RENAL PAIN 70 0.0066
449 CHOLELITHIASIS 216 0.0066
450 DYSPNOEA 3716 0.0066
451 PLEURAL EFFUSION 398 0.0065
452 LIPASE INCREASED 50 0.0065
453 LYMPHOCYTE COUNT DECREASED 115 0.0065
454 ANAL ABSCESS 35 0.0065
455 HYPERTRIGLYCERIDAEMIA 38 0.0065
456 INCOHERENT 42 0.0065
457 ABDOMINAL PAIN UPPER 1328 0.0064
458 PANCREATITIS 339 0.0064
459 PROTEINURIA 121 0.0064
460 POLYURIA 52 0.0063
461 DRUG INTERACTION 1007 0.0063
462 DERMATITIS 133 0.0063
463 DRUG DOSE OMISSION 1040 0.0063
464 DYSPEPSIA 619 0.0063
465 UROSEPSIS 58 0.0063
466 DIZZINESS 3122 0.0063
467 SKIN INFECTION 70 0.0062
468 COUGH 1745 0.0062
469 SKIN TOXICITY 35 0.0062
470 ANURIA 53 0.0062
471 BLOOD MAGNESIUM DECREASED 53 0.0061
472 OEDEMA PERIPHERAL 746 0.0061
473 ABDOMINAL DISTENSION 631 0.0060
474 RASH PUSTULAR 44 0.0060
475 HAEMODYNAMIC INSTABILITY 46 0.0060
476 BONE PAIN 353 0.0060
477 BLOOD THYROID STIMULATING HORMONE INCREASED 55 0.0060
478 BLOOD CALCIUM DECREASED 67 0.0060
479 LYMPHOMA 92 0.0059
480 MELAENA 130 0.0059
481 HEPATITIS 151 0.0059
482 SUNBURN 44 0.0059
483 CONFUSIONAL STATE 949 0.0059
484 EAR PAIN 114 0.0059
485 LACERATION 55 0.0058
486 LIP DRY 53 0.0058
487 HAEMODIALYSIS 49 0.0058
488 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 414 0.0058
489 PERSONALITY CHANGE 54 0.0058
490 COLITIS 220 0.0058
491 GOUT 104 0.0058
492 PURPURA 51 0.0058
493 POOR QUALITY SLEEP 124 0.0058
494 INTESTINAL OBSTRUCTION 217 0.0058
495 VIRAL INFECTION 191 0.0057
496 CELLULITIS 289 0.0057
497 URINE OUTPUT DECREASED 50 0.0057
498 THERAPY NON-RESPONDER 257 0.0057
499 GLOMERULAR FILTRATION RATE DECREASED 70 0.0057
500 MENTAL STATUS CHANGES 158 0.0057
501 HYPOPHOSPHATAEMIA 42 0.0057
502 TACHYCARDIA 504 0.0057
503 STEVENS-JOHNSON SYNDROME 126 0.0057
504 OROPHARYNGEAL PAIN 524 0.0057
505 COAGULOPATHY 94 0.0056
506 BRAIN OEDEMA 71 0.0056
507 DISORIENTATION 222 0.0056
508 TOOTH ABSCESS 57 0.0056
509 POLYNEUROPATHY 67 0.0056
510 MUCOSAL INFLAMMATION 146 0.0056
511 RENAL DISORDER 259 0.0056
512 BLOOD LACTATE DEHYDROGENASE INCREASED 87 0.0055
513 VISUAL ACUITY REDUCED 182 0.0055
514 BLOOD URINE PRESENT 104 0.0055
515 AMNESIA 356 0.0055
516 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 45 0.0055
517 GENERAL PHYSICAL CONDITION ABNORMAL 37 0.0054
518 MALAISE 2386 0.0054
519 INTERSTITIAL LUNG DISEASE 262 0.0054
520 SUICIDAL IDEATION 495 0.0054
521 FUNGAL INFECTION 180 0.0054
522 ILEUS 67 0.0054
523 PANIC ATTACK 196 0.0054
524 GAMMA-GLUTAMYLTRANSFERASE INCREASED 119 0.0054
525 NIGHT SWEATS 173 0.0054
526 PNEUMONITIS 146 0.0054
527 EMPHYSEMA 54 0.0053
528 AFFECTIVE DISORDER 42 0.0053
529 COLITIS ISCHAEMIC 36 0.0053
530 PNEUMOTHORAX 84 0.0053
531 HYPERGLYCAEMIA 193 0.0053
532 HYPONATRAEMIA 298 0.0053
533 ACUTE KIDNEY INJURY 809 0.0053
534 FACIAL PARALYSIS 45 0.0053
535 PERICARDIAL EFFUSION 122 0.0053
536 THERAPY PARTIAL RESPONDER 82 0.0053
537 DRUG LEVEL INCREASED 87 0.0053
538 PAPULE 37 0.0052
539 CHEST PAIN 972 0.0052
540 TOOTHACHE 95 0.0052
541 PHARYNGITIS 65 0.0052
542 CONSTIPATION 1142 0.0052
543 POLLAKIURIA 217 0.0052
544 NEUTROPENIC SEPSIS 37 0.0052
545 INTESTINAL PERFORATION 58 0.0052
546 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
547 MEMORY IMPAIRMENT 704 0.0051
548 DERMATITIS BULLOUS 37 0.0051
549 INCREASED TENDENCY TO BRUISE 47 0.0051
550 SUBARACHNOID HAEMORRHAGE 52 0.0051
551 OEDEMA 275 0.0051
552 HEPATOTOXICITY 112 0.0050
553 HYPERKALAEMIA 176 0.0050
554 BLOOD TRIGLYCERIDES INCREASED 88 0.0050
555 PNEUMONIA 1608 0.0050
556 COLON CANCER 74 0.0050
557 FEBRILE NEUTROPENIA 328 0.0049
558 UVEITIS 67 0.0049
559 RESPIRATORY SYNCYTIAL VIRUS INFECTION 43 0.0049
560 ANXIETY 1404 0.0049
561 CONVULSION 282 0.0049
562 MAJOR DEPRESSION 36 0.0049
563 LIVER FUNCTION TEST ABNORMAL 143 0.0049
564 URINARY TRACT INFECTION 835 0.0049
565 EATING DISORDER 104 0.0049
566 VITREOUS FLOATERS 48 0.0049
567 DISEASE RECURRENCE 232 0.0049
568 MANIA 80 0.0049
569 CEREBRAL HAEMORRHAGE 174 0.0049
570 METASTASES TO LUNG 56 0.0048
571 LABORATORY TEST ABNORMAL 143 0.0048
572 SWELLING FACE 315 0.0048
573 IMMUNODEFICIENCY 72 0.0048
574 MUSCULOSKELETAL PAIN 252 0.0048
575 GASTROINTESTINAL HAEMORRHAGE 402 0.0048
576 WHITE BLOOD CELL COUNT INCREASED 184 0.0048
577 THINKING ABNORMAL 89 0.0048
578 ABASIA 118 0.0048
579 GRAND MAL CONVULSION 44 0.0048
580 EOSINOPHILIA 83 0.0047
581 ACIDOSIS 36 0.0047
582 LOSS OF CONSCIOUSNESS 603 0.0047
583 MENTAL IMPAIRMENT 114 0.0047
584 PULMONARY CONGESTION 62 0.0047
585 SUPRAVENTRICULAR TACHYCARDIA 45 0.0047
586 PETECHIAE 49 0.0047
587 INFECTION 679 0.0047
588 ORAL DISCOMFORT 65 0.0047
589 PRODUCTIVE COUGH 223 0.0047
590 DRUG-INDUCED LIVER INJURY 146 0.0046
591 BEDRIDDEN 61 0.0046
592 TACHYPNOEA 63 0.0046
593 VERTIGO 282 0.0046
594 GASTROENTERITIS VIRAL 83 0.0046
595 PRODUCT DOSE OMISSION IN ERROR 130 0.0046
596 PERIPHERAL COLDNESS 63 0.0046
597 DEATH 3938 0.0046
598 SHOCK 105 0.0046
599 RESPIRATORY DISORDER 136 0.0045
600 TUBULOINTERSTITIAL NEPHRITIS 85 0.0045
601 PRODUCT DISTRIBUTION ISSUE 42 0.0045
602 APATHY 66 0.0045
603 INJECTION SITE REACTION 311 0.0045
604 ABNORMAL FAECES 37 0.0045
605 ABSCESS 72 0.0045
606 KIDNEY INFECTION 88 0.0045
607 BLOOD ALKALINE PHOSPHATASE INCREASED 111 0.0045
608 ATAXIA 53 0.0045
609 MUSCULOSKELETAL CHEST PAIN 69 0.0045
610 BACK PAIN 1035 0.0045
611 DENTAL CARIES 49 0.0044
612 TOOTH EXTRACTION 55 0.0044
613 AGGRESSION 221 0.0044
614 METABOLIC ACIDOSIS 140 0.0044
615 FREQUENT BOWEL MOVEMENTS 118 0.0044
616 SLEEP DISORDER 308 0.0044
617 PERICARDITIS 73 0.0043
618 NEUROPATHY PERIPHERAL 413 0.0043
619 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 237 0.0043
620 AUTOIMMUNE DISORDER 42 0.0043
621 HYPERHIDROSIS 555 0.0043
622 SCAB 49 0.0043
623 AGEUSIA 107 0.0043
624 PREGNANCY 85 0.0042
625 SENSORY DISTURBANCE 68 0.0042
626 FEELING HOT 259 0.0042
627 PAIN 2590 0.0042
628 STENT PLACEMENT 34 0.0042
629 EYELID OEDEMA 49 0.0042
630 RESPIRATORY TRACT INFECTION 109 0.0042
631 LUNG DISORDER 205 0.0042
632 INJECTION SITE ERYTHEMA 518 0.0042
633 ABDOMINAL DISCOMFORT 700 0.0042
634 LEUKOCYTOSIS 75 0.0041
635 FEELING ABNORMAL 991 0.0041
636 HYPERTENSIVE CRISIS 46 0.0041
637 HEPATIC ENZYME INCREASED 281 0.0041
638 EYE HAEMORRHAGE 55 0.0041
639 IMPAIRED WORK ABILITY 88 0.0041
640 HAIR TEXTURE ABNORMAL 55 0.0041
641 DRUG ADMINISTRATION ERROR 126 0.0041
642 PERITONITIS 85 0.0041
643 FOLLICULITIS 43 0.0041
644 SKIN FISSURES 80 0.0041
645 INCORRECT DRUG ADMINISTRATION DURATION 115 0.0041
646 EYE SWELLING 152 0.0041
647 SUDDEN DEATH 43 0.0041
648 HYPOXIA 143 0.0041
649 EAR INFECTION 108 0.0041
650 NERVOUSNESS 212 0.0041
651 FLATULENCE 229 0.0040
652 AGITATION 295 0.0040
653 HALLUCINATION 301 0.0040
654 CARDIOMYOPATHY 59 0.0040
655 DYSARTHRIA 150 0.0040
656 ACUTE CORONARY SYNDROME 33 0.0040
657 HEPATIC STEATOSIS 74 0.0040
658 ABDOMINAL PAIN LOWER 100 0.0040
659 LIVER INJURY 97 0.0039
660 TREATMENT NONCOMPLIANCE 216 0.0039
661 ARTHRALGIA 1641 0.0039
662 DIALYSIS 56 0.0039
663 BLOOD GLUCOSE FLUCTUATION 43 0.0039
664 LACTIC ACIDOSIS 127 0.0039
665 SOMNOLENCE 789 0.0039
666 NEOPLASM 45 0.0039
667 PULMONARY FIBROSIS 75 0.0039
668 DEAFNESS 102 0.0039
669 FEEDING DISORDER 79 0.0039
670 PULMONARY MASS 58 0.0039
671 BLOOD POTASSIUM INCREASED 63 0.0039
672 DRUG INEFFECTIVE 5111 0.0039
673 NOCTURIA 47 0.0039
674 PULMONARY ARTERIAL HYPERTENSION 56 0.0039
675 DELIRIUM 133 0.0038
676 CYSTITIS 122 0.0038
677 SWOLLEN TONGUE 119 0.0038
678 FACIAL PAIN 34 0.0038
679 COLD SWEAT 67 0.0038
680 DEEP VEIN THROMBOSIS 247 0.0038
681 PALPITATIONS 445 0.0038
682 MYOSITIS 34 0.0038
683 CONJUNCTIVITIS 70 0.0038
684 BIPOLAR DISORDER 41 0.0038
685 BRONCHITIS 279 0.0038
686 HYPERLIPIDAEMIA 45 0.0038
687 HYPOTENSION 755 0.0038
688 CIRCULATORY COLLAPSE 64 0.0038
689 DIABETES MELLITUS 286 0.0037
690 ASPIRATION 41 0.0037
691 OFF LABEL USE 3278 0.0037
692 TREMOR 621 0.0037
693 MUSCLE SPASMS 686 0.0037
694 GASTROOESOPHAGEAL REFLUX DISEASE 300 0.0037
695 HALLUCINATION, AUDITORY 59 0.0037
696 CLOSTRIDIUM DIFFICILE INFECTION 81 0.0037
697 DYSPHONIA 217 0.0037
698 NEUROTOXICITY 65 0.0037
699 METASTASES TO LIVER 65 0.0037
700 GASTROINTESTINAL DISORDER 331 0.0037
701 GENERAL PHYSICAL HEALTH DETERIORATION 427 0.0037
702 CONTUSION 355 0.0037
703 FULL BLOOD COUNT ABNORMAL 39 0.0037
704 SKIN EXFOLIATION 311 0.0037
705 DRY EYE 184 0.0037
706 SKIN DISCOLOURATION 169 0.0037
707 DECREASED IMMUNE RESPONSIVENESS 36 0.0037
708 RESTLESSNESS 133 0.0036
709 INTENTIONAL PRODUCT USE ISSUE 317 0.0036
710 HEMIPARESIS 61 0.0036
711 HYPOCALCAEMIA 68 0.0036
712 UPPER RESPIRATORY TRACT INFECTION 166 0.0036
713 ULCER 57 0.0036
714 HYPOAESTHESIA 536 0.0036
715 INTERNATIONAL NORMALISED RATIO INCREASED 102 0.0036
716 DERMATITIS ALLERGIC 45 0.0036
717 RESTLESS LEGS SYNDROME 65 0.0036
718 DEVICE RELATED INFECTION 55 0.0036
719 VISUAL IMPAIRMENT 442 0.0036
720 MIGRAINE 340 0.0036
721 ACTIVITIES OF DAILY LIVING IMPAIRED 70 0.0035
722 DYSPHAGIA 334 0.0035
723 PULMONARY OEDEMA 157 0.0035
724 TEMPERATURE INTOLERANCE 36 0.0035
725 NEPHROLITHIASIS 160 0.0035
726 INFLUENZA 389 0.0035
727 HERPES ZOSTER 200 0.0035
728 FLUID RETENTION 177 0.0035
729 ECZEMA 182 0.0035
730 TOOTH FRACTURE 38 0.0034
731 MALIGNANT NEOPLASM PROGRESSION 351 0.0034
732 BLOOD PRESSURE INCREASED 522 0.0034
733 CHOLECYSTECTOMY 39 0.0034
734 TOOTH INFECTION 45 0.0034
735 ERUCTATION 66 0.0034
736 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 35 0.0034
737 SINUS CONGESTION 46 0.0034
738 RHABDOMYOLYSIS 141 0.0034
739 SINUS TACHYCARDIA 48 0.0034
740 TRANSIENT ISCHAEMIC ATTACK 114 0.0034
741 POST PROCEDURAL COMPLICATION 64 0.0033
742 THROMBOSIS 268 0.0033
743 C-REACTIVE PROTEIN INCREASED 121 0.0033
744 MYOCARDITIS 38 0.0033
745 EAR DISCOMFORT 34 0.0033
746 HAEMORRHAGE 341 0.0033
747 MENORRHAGIA 64 0.0033
748 HYPERCALCAEMIA 40 0.0032
749 EYE IRRITATION 186 0.0032
750 SCRATCH 34 0.0032
751 COVID-19 PNEUMONIA 38 0.0032
752 SUBDURAL HAEMATOMA 46 0.0032
753 ANGINA PECTORIS 92 0.0032
754 DIABETIC KETOACIDOSIS 77 0.0032
755 BASAL CELL CARCINOMA 50 0.0032
756 CHEST DISCOMFORT 327 0.0032
757 EPILEPSY 97 0.0032
758 CARDIAC ARREST 261 0.0032
759 OCULAR HYPERAEMIA 150 0.0032
760 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 73 0.0031
761 PULMONARY THROMBOSIS 34 0.0031
762 ACCIDENTAL OVERDOSE 114 0.0031
763 WOUND INFECTION 34 0.0031
764 HEART RATE INCREASED 307 0.0031
765 MUSCLE TIGHTNESS 50 0.0031
766 PULMONARY HYPERTENSION 64 0.0031
767 PHARYNGEAL OEDEMA 47 0.0031
768 CARDIAC FAILURE 245 0.0030
769 BURNING SENSATION 214 0.0030
770 PAIN OF SKIN 82 0.0030
771 GASTRIC HAEMORRHAGE 35 0.0030
772 ARRHYTHMIA 144 0.0030
773 NECK PAIN 169 0.0030
774 FLUID OVERLOAD 44 0.0030
775 SCIATICA 48 0.0030
776 BALANCE DISORDER 260 0.0030
777 ABNORMAL DREAMS 83 0.0030
778 MEDICATION ERROR 167 0.0030
779 HYPERTENSION 635 0.0030
780 DIABETES MELLITUS INADEQUATE CONTROL 53 0.0030
781 MYOCARDIAL ISCHAEMIA 34 0.0030
782 HALLUCINATION, VISUAL 63 0.0030
783 BLINDNESS UNILATERAL 42 0.0030
784 INJECTION SITE BRUISING 237 0.0030
785 BLOOD PRESSURE DECREASED 197 0.0030
786 BLOOD CREATINE PHOSPHOKINASE INCREASED 85 0.0029
787 ACUTE MYOCARDIAL INFARCTION 87 0.0029
788 EYE DISORDER 97 0.0029
789 NERVOUS SYSTEM DISORDER 92 0.0029
790 APHONIA 41 0.0029
791 PNEUMONIA ASPIRATION 73 0.0029
792 PLATELET COUNT INCREASED 38 0.0029
793 TOOTH LOSS 60 0.0029
794 RHINORRHOEA 187 0.0029
795 COGNITIVE DISORDER 135 0.0029
796 PAIN IN EXTREMITY 846 0.0029
797 ADVERSE REACTION 38 0.0029
798 CARDIOMEGALY 35 0.0028
799 PRODUCT USE IN UNAPPROVED INDICATION 704 0.0028
800 LOWER RESPIRATORY TRACT INFECTION 128 0.0028
801 HEAD INJURY 89 0.0028
802 PRODUCT USE ISSUE 528 0.0028
803 COORDINATION ABNORMAL 39 0.0028
804 DRUG INTOLERANCE 270 0.0028
805 LACRIMATION INCREASED 84 0.0028
806 SINUS DISORDER 55 0.0028
807 RESPIRATORY TRACT CONGESTION 44 0.0028
808 GASTRIC DISORDER 95 0.0028
809 ABNORMAL BEHAVIOUR 109 0.0027
810 SCAR 47 0.0027
811 ATRIAL FIBRILLATION 267 0.0027
812 EYE PRURITUS 92 0.0027
813 MUSCULAR WEAKNESS 311 0.0027
814 INCREASED APPETITE 52 0.0027
815 WEIGHT INCREASED 609 0.0027
816 ORTHOSTATIC HYPOTENSION 47 0.0027
817 INJECTION SITE HAEMATOMA 39 0.0027
818 BLOOD GLUCOSE DECREASED 128 0.0027
819 FALL 886 0.0027
820 PSYCHOMOTOR HYPERACTIVITY 44 0.0026
821 CONDITION AGGRAVATED 801 0.0026
822 SKIN HAEMORRHAGE 39 0.0026
823 CORONARY ARTERY OCCLUSION 36 0.0026
824 HEPATOCELLULAR INJURY 37 0.0026
825 HAEMATOMA 67 0.0026
826 URINARY RETENTION 86 0.0026
827 GLAUCOMA 49 0.0025
828 URINARY INCONTINENCE 75 0.0025
829 PARAESTHESIA 396 0.0025
830 ERYTHEMA 515 0.0025
831 DRUG TOXICITY 34 0.0025
832 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 130 0.0025
833 SUICIDE ATTEMPT 151 0.0025
834 ROAD TRAFFIC ACCIDENT 104 0.0025
835 APHASIA 75 0.0025
836 DEPRESSED LEVEL OF CONSCIOUSNESS 98 0.0025
837 PULMONARY EMBOLISM 235 0.0025
838 GALLBLADDER DISORDER 44 0.0025
839 ADVERSE EVENT 226 0.0024
840 NASAL CONGESTION 144 0.0024
841 SINUSITIS 251 0.0024
842 SPEECH DISORDER 128 0.0024
843 NASOPHARYNGITIS 450 0.0024
844 THERAPEUTIC RESPONSE DECREASED 148 0.0024
845 TASTE DISORDER 49 0.0024
846 FEELING JITTERY 46 0.0024
847 UNRESPONSIVE TO STIMULI 62 0.0024
848 CENTRAL NERVOUS SYSTEM LESION 33 0.0024
849 VAGINAL HAEMORRHAGE 104 0.0024
850 MUSCLE TWITCHING 55 0.0024
851 TOOTH DISORDER 53 0.0024
852 CARDIOGENIC SHOCK 34 0.0024
853 NEURALGIA 57 0.0023
854 INJECTION SITE PRURITUS 156 0.0023
855 HYPOAESTHESIA ORAL 35 0.0023
856 MUSCULOSKELETAL DISORDER 44 0.0023
857 ISCHAEMIC STROKE 41 0.0023
858 IMPAIRED HEALING 75 0.0023
859 HERNIA 44 0.0023
860 OSTEOMYELITIS 41 0.0023
861 COLITIS ULCERATIVE 101 0.0023
862 LIP SWELLING 75 0.0022
863 BRADYCARDIA 119 0.0022
864 GENERALISED TONIC-CLONIC SEIZURE 37 0.0022
865 UNEVALUABLE EVENT 169 0.0022
866 HYPOGLYCAEMIA 108 0.0022
867 PAIN IN JAW 63 0.0022
868 ABORTION SPONTANEOUS 89 0.0022
869 CEREBRAL INFARCTION 54 0.0022
870 MUSCULOSKELETAL DISCOMFORT 38 0.0022
871 LOCALISED INFECTION 53 0.0022
872 LIVER FUNCTION TEST INCREASED 47 0.0022
873 DELUSION 34 0.0022
874 SWELLING 203 0.0022
875 ERECTILE DYSFUNCTION 55 0.0021
876 RIB FRACTURE 44 0.0021
877 BLOOD GLUCOSE INCREASED 401 0.0021
878 SKIN IRRITATION 96 0.0021
879 GAIT DISTURBANCE 397 0.0021
880 BLOOD GLUCOSE ABNORMAL 38 0.0021
881 FIBROMYALGIA 50 0.0021
882 DYSSTASIA 60 0.0021
883 IRRITABLE BOWEL SYNDROME 44 0.0021
884 THROAT IRRITATION 91 0.0020
885 UNDERDOSE 148 0.0020
886 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 364 0.0020
887 URTICARIA 338 0.0020
888 NIGHTMARE 69 0.0020
889 CHRONIC KIDNEY DISEASE 151 0.0020
890 INTERVERTEBRAL DISC PROTRUSION 43 0.0020
891 CYTOKINE RELEASE SYNDROME 39 0.0019
892 CARDIOVASCULAR DISORDER 49 0.0019
893 INTENTIONAL DOSE OMISSION 55 0.0019
894 THERAPY CESSATION 98 0.0019
895 FOOT FRACTURE 36 0.0019
896 SKIN BURNING SENSATION 136 0.0019
897 CATARACT 113 0.0019
898 PERIPHERAL SWELLING 287 0.0019
899 FEAR 50 0.0019
900 HEART RATE IRREGULAR 42 0.0019
901 DYSKINESIA 75 0.0018
902 JOINT STIFFNESS 48 0.0018
903 DIVERTICULITIS 50 0.0018
904 MOVEMENT DISORDER 57 0.0018
905 ANHEDONIA 46 0.0017
906 NO ADVERSE EVENT 315 0.0017
907 DRUG EFFECT INCOMPLETE 63 0.0017
908 HOT FLUSH 130 0.0017
909 MYOCARDIAL INFARCTION 296 0.0017
910 ADVERSE DRUG REACTION 152 0.0017
911 HEART RATE DECREASED 59 0.0017
912 EXTRA DOSE ADMINISTERED 68 0.0017
913 WHEEZING 99 0.0017
914 TYPE 2 DIABETES MELLITUS 56 0.0017
915 OXYGEN SATURATION DECREASED 93 0.0017
916 SNEEZING 37 0.0016
917 RENAL INJURY 49 0.0016
918 JOINT SWELLING 197 0.0016
919 INJECTION SITE MASS 60 0.0016
920 CEREBROVASCULAR ACCIDENT 273 0.0016
921 SEIZURE 184 0.0016
922 PROCEDURAL PAIN 44 0.0016
923 HYPERSENSITIVITY 292 0.0016
924 TOXICITY TO VARIOUS AGENTS 265 0.0016
925 ILL-DEFINED DISORDER 95 0.0016
926 NEOPLASM PROGRESSION 53 0.0015
927 RESPIRATORY ARREST 42 0.0015
928 INJECTION SITE HAEMORRHAGE 121 0.0015
929 LIMB INJURY 41 0.0015
930 THERAPEUTIC RESPONSE UNEXPECTED 67 0.0015
931 THERAPY INTERRUPTED 106 0.0015
932 CARDIAC FAILURE CONGESTIVE 117 0.0015
933 PSORIASIS 189 0.0014
934 THROAT TIGHTNESS 39 0.0014
935 WOUND 40 0.0014
936 CORONARY ARTERY DISEASE 43 0.0014
937 ASTHMA 160 0.0014
938 MUSCULOSKELETAL STIFFNESS 124 0.0014
939 INFLAMMATION 73 0.0014
940 OVERDOSE 304 0.0014
941 EXPOSURE DURING PREGNANCY 87 0.0014
942 ARTHRITIS 110 0.0014
943 CARDIAC DISORDER 129 0.0014
944 HOSPITALISATION 211 0.0014
945 ANGIOEDEMA 60 0.0014
946 INCORRECT DOSE ADMINISTERED 300 0.0013
947 PREMATURE BABY 39 0.0013
948 ELECTROCARDIOGRAM QT PROLONGED 46 0.0013
949 DISCOMFORT 77 0.0013
950 PRODUCT QUALITY ISSUE 170 0.0013
951 OSTEOPOROSIS 51 0.0012
952 MOBILITY DECREASED 89 0.0012
953 SURGERY 67 0.0011
954 ILLNESS 117 0.0011
955 OSTEONECROSIS 36 0.0011
956 LUNG NEOPLASM MALIGNANT 45 0.0011
957 DRUG EXPOSURE DURING PREGNANCY 37 0.0011
958 OSTEOARTHRITIS 46 0.0011
959 GAIT INABILITY 36 0.0011
960 SYSTEMIC LUPUS ERYTHEMATOSUS 38 0.0011
961 HIP FRACTURE 34 0.0011
962 WRONG TECHNIQUE IN DRUG USAGE PROCESS 38 0.0010
963 MATERNAL EXPOSURE DURING PREGNANCY 90 0.0010
964 NEOPLASM MALIGNANT 65 0.0010
965 BLOOD CHOLESTEROL INCREASED 45 0.0010
966 FOETAL EXPOSURE DURING PREGNANCY 78 0.0010
967 ACNE 69 0.0009
968 COVID-19 159 0.0009
969 INJECTION SITE SWELLING 67 0.0009
970 WITHDRAWAL SYNDROME 36 0.0009
971 EMOTIONAL DISTRESS 102 0.0008
972 FLUSHING 84 0.0008
973 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 58 0.0008
974 PRODUCT DOSE OMISSION 53 0.0008
975 DRUG EFFECT DECREASED 43 0.0008
976 INJURY 56 0.0008
977 ARTHROPATHY 44 0.0008
978 ANAPHYLACTIC REACTION 42 0.0008
979 DRUG ABUSE 61 0.0007
980 COMPLETED SUICIDE 52 0.0006
981 INJECTION SITE PAIN 184 0.0006
982 ACCIDENTAL EXPOSURE TO PRODUCT 55 0.0005
983 RHEUMATOID ARTHRITIS 59 0.0005
984 DRUG WITHDRAWAL SYNDROME 43 0.0005
985 DRUG DEPENDENCE 78 0.0005
986 INTENTIONAL PRODUCT MISUSE 36 0.0004
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 81 0.0004
988 BREAST CANCER 34 0.0004
989 PRODUCT DOSE OMISSION ISSUE 103 0.0003